| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 348,637 | 360,525 | 347,846 | 322,876 | | Cost of Revenue | 193,204 | 194,181 | 192,412 | 170,410 | | | Gross Profit | 155,433 | 166,344 | 155,434 | 152,466 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 84,976 | 88,842 | 88,753 | 88,199 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,171 | 6,149 | 6,050 | 5,805 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 64,286 | 71,353 | 60,631 | 58,462 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,330 | 702 | 2,303 | 2,559 | | Earnings Before Interest And Taxes | 67,616 | 72,055 | 62,934 | 61,021 | | Interest Expense | 11,434 | 11,030 | 11,013 | 11,420 | | Income Before Tax | 56,182 | 61,025 | 51,921 | 49,601 | | Income Tax Expense | 18,626 | 23,800 | 20,249 | 18,408 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,556 | 37,225 | 31,672 | 31,193 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,556 | 37,225 | 31,672 | 31,193 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,556 | $37,225 | $31,672 | $31,193 |
|
0.02% Nasdaq 0.00%
Income Statement
